bibliographicCitation |
Mitsuboshi S, Niimura T, Kanda M, Ishida S, Zamami Y, Ishizawa K. Risk of Hematologic Events With Coadministration of Methotrexate and the Breast Cancer Resistance Protein Inhibitor Febuxostat. Ann Pharmacother. 2022 Aug;56(8):910–5. doi: 10.1177/10600280211055794. PMID: 34726078. |